Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Various Advanced Cancer × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 130 Stomach Neoplasms 46 Neoplasms 42 Pancreatic Neoplasms 37 Neoplasm Metastasis 29 Esophageal Neoplasms 24 Head and Neck Neoplasms 22 Rectal Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 19 Colonic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Breast Neoplasms 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 15 Adenocarcinoma Of Esophagus 12 Adenocarcinoma 12 Esophageal Squamous Cell Carcinoma 11 Cholangiocarcinoma 11 Ovarian Neoplasms 7 Gallbladder Neoplasms 7 Biliary Tract Neoplasms 7 Triple Negative Breast Neoplasms 6 Keratosis, Actinic 6 Carcinoma, Hepatocellular 6 Advanced Solid Tumors 6 Urinary Bladder Neoplasms 5 Lung Neoplasms 5 Digestive System Neoplasms 5 Carcinoma 5 Solid Tumors 4 Sarcoma 4

Interventions

Nivolumab 4 Ipilimumab 2 Fluorouracil 1 Cisplatin 1 BMS-986115 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡